NCT01446432View on ClinicalTrials.gov

Validation of Two New Questionnaires for Dupuytren's Disease

UnknownOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Dupuytren's Disease
Trial Locations (1)

10021

Hospital For Special Surgery, New York

Sponsors
All Listed Sponsors
collaborator

Auxilium Pharmaceuticals, Inc.

INDUSTRY

lead

Robert Hotchkiss

OTHER

NCT01446432 - Validation of Two New Questionnaires for Dupuytren's Disease | Biotech Hunter | Biotech Hunter